Thromb Haemost 1978; 39(02): 450-454
DOI: 10.1055/s-0038-1646704
Original Article
Schattauer GmbH Stuttgart

The Effect of Plasma Fibrinogen Levels on Measures of Fibrinolytic Activity

R Chakrabarti
The MRC/DHSS Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, England
,
W R S North
The MRC/DHSS Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, England
,
T W Meade
The MRC/DHSS Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, England
› Author Affiliations
Further Information

Publication History

Received 26 June 1977

Accepted 06 October 1977

Publication Date:
12 July 2018 (online)

Summary

It has been claimed that lysis time methods may be inappropriate as measures of fibrinolytic activity on the grounds that they are largely determined by plasma fibrinogen levels. The dilute blood clot lysis time (DBCLT) has therefore been measured in 103 subjects; fibrinolytic activity (expressed as 100/DBCLT) has been compared with the fibrin plate area (FPA) lysed by the euglobulin fraction, the latter method being, of course, virtually independent of plasma fibrinogen. Plasma fibrinogen levels have also been measured; they ranged from 167 to 416 mg%. Results have been analysed by the technique of multiple regression. The incorporation of plasma fibrinogen levels in the regression equation relating 100/DBCLT to FPA does not result in a significant increase in the proportion of the variance in 100/DBCLT that can be explained. It is concluded that there is no evidence that DBCLT is influenced by plasma fibrinogen levels within the physiological range.

 
  • References

  • 1 ASTRUP T, Müllertz S. 1952; The fibrin plate method for estimating fibrinolytic activity. Archives of Biochemistry 40: 346
  • 2 Chakrabarti R, Bielawiec M, Evans JF, Fearnley GR. 1968; Methodological study and a recommended technique for determining the euglobulin lysis time. Journal of Clinical Pathology 21: 698
  • 3 Chakrabarti R, Hocking ED, Fearnley GR. 1969; Reaction pattern to three stresses – electroplexy, surgery and myocardial infarction – of fibrinolysis and plasma fibrinogen. Journal of Clinical Pathology 22: 659
  • 4 Fearnley GR, Balmforth G, Fearnley E. 1957; Evidence of a diurnal rhythm with a simple method of measuring natural fibrinolysis. Clinical Science 16: 645
  • 5 Fearnley GR, Chakrabarti R. 1962; Increase of blood fibrinolytic activity by testosterone. Lancet II: 128
  • 6 Fearnley GR, Chakarabarti R. 1966; Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol. Lancet II: 757
  • 7 Fearnley GR, Chakrabarti R, Evans JF. 1971; Mode of action of phenformin plus ethyloestrenol on fibrinolysis. Lancet II: 723
  • 8 Gallimore MJ, Shaw JTB. 1969; The influence of various plasma components on the lysis of diluted human blood clots. Thrombosis et Diathesis Haemorrhagica 22: 223
  • 9 Hickman JA, Gordon-Smith IC, Whitfield PF, Godfrey SJ. 1973; The relationship of the dilute whole blood lysis time to the fibrinolytic activity of blood: effect of change in plasma fibrinogen. Journal of Clinical Pathology 26: 189
  • 10 Macintyre IMC, Webber RG, Crispin JR, Jones DRB, Wood JK, Allan NC, Prescott RJ, Ruckley CV. 1976; Plasma fibrinolysis and post-operative deep vein thrombosis. British Journal of Surgery 63: 694
  • 11 Merrils RJ, Shaw JTB. 1968; Kinetics of fibrin clot lysis. Biochemical Journal 106: 101
  • 12 Meade TW, North WRS. 1977 British Medical Bulletin (in press).
  • 13 Von Kaulla KN, Schultz RL. 1958; Methods for evaluation of human fibrinolysis: Studies with two combined techniques. American Journal of Clinical Pathology 29: 104
  • 14 Wolf P. 1967; Coagulation fibrinolysis. Lancet I: 1226